Methergine

Methergine is a brand name of methylergonovine, approved by the FDA in the following formulation(s):

METHERGINE (methylergonovine maleate - injectable; injection)

• 
  Manufacturer: NOVARTIS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 0.2MG/ML ^[RLD][AP]

METHERGINE (methylergonovine maleate - tablet; oral)

• 
  Manufacturer: NOVARTIS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 0.2MG ^[RLD][AB]

Has a generic version of Methergine been approved?

Yes. The following products are equivalent to Methergine:

methylergonovine maleate injectable; injection

• 
  Manufacturer: ERGOJECT
  
  Approval date: September 13, 2010
  
  Strength(s): 0.2MG/ML ^[AP]


• 
  Manufacturer: LUITPOLD
  
  Approval date: November 24, 2008
  
  Strength(s): 0.2MG/ML ^[AP]

methylergonovine maleate tablet; oral

• 
  Manufacturer: NOVEL LABS INC
  
  Approval date: May 2, 2011
  
  Strength(s): 0.2MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Methergine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Methergine.

See also...

• Methergine Consumer Information (Wolters Kluwer)
• Methergine Tablets Consumer Information (Wolters Kluwer)
• Methergine oral and injectable Consumer Information (Cerner Multum)
• Methylergonovine Consumer Information (Wolters Kluwer)
• Methylergonovine Tablets Consumer Information (Wolters Kluwer)
• Methylergonovine oral and injectable Consumer Information (Cerner Multum)